药明康德:高盛上调目标价,业绩强劲

和讯网
Yesterday

【4 月 30 日,高盛发布研究报告称药明康德今年首季业绩强劲】高盛指出,药明康德管理层维持其 2025 财年指引,符合预期,若未来 1 至 2 个季度持续强势,公司下半年或提高指引。该行预计公司的 TIDES 业务今年增长 65%,上调 2025 年至 2027 年各年的 TIDES 收入预测。高盛还上调对公司 2025 年至 2027 年各年纯利预测,并将 H 股目标价由 70.9 港元升至 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10